Correlation Between Teva Pharmaceutical and Palram

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharmaceutical and Palram at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharmaceutical and Palram into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharmaceutical Industries and Palram, you can compare the effects of market volatilities on Teva Pharmaceutical and Palram and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharmaceutical with a short position of Palram. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharmaceutical and Palram.

Diversification Opportunities for Teva Pharmaceutical and Palram

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Teva and Palram is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and Palram in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palram and Teva Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharmaceutical Industries are associated (or correlated) with Palram. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palram has no effect on the direction of Teva Pharmaceutical i.e., Teva Pharmaceutical and Palram go up and down completely randomly.

Pair Corralation between Teva Pharmaceutical and Palram

Assuming the 90 days trading horizon Teva Pharmaceutical Industries is expected to under-perform the Palram. In addition to that, Teva Pharmaceutical is 1.18 times more volatile than Palram. It trades about -0.1 of its total potential returns per unit of risk. Palram is currently generating about 0.59 per unit of volatility. If you would invest  687,400  in Palram on September 13, 2024 and sell it today you would earn a total of  152,900  from holding Palram or generate 22.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Teva Pharmaceutical Industries  vs.  Palram

 Performance 
       Timeline  
Teva Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Teva Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Palram 

Risk-Adjusted Performance

30 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Palram are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Palram sustained solid returns over the last few months and may actually be approaching a breakup point.

Teva Pharmaceutical and Palram Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharmaceutical and Palram

The main advantage of trading using opposite Teva Pharmaceutical and Palram positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharmaceutical position performs unexpectedly, Palram can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palram will offset losses from the drop in Palram's long position.
The idea behind Teva Pharmaceutical Industries and Palram pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities